PDCD1 and neoplasm: Since our main goal was to determine whether the combination of these two agents improved the reduction of tumor growth when compared to single agents, we selected the suboptimal concentrations of 15 mg/kg for NextA and 3.0 mg/kg for anti-PD-1.